Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 26
1999 40
2000 49
2001 49
2002 45
2003 56
2004 88
2005 155
2006 155
2007 134
2008 169
2009 201
2010 198
2011 228
2012 244
2013 274
2014 286
2015 132
2016 101
2017 116
2018 120
2019 75
2020 79
2021 92
2022 95
2023 85
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

2,609 results

Results by year

Filters applied: . Clear all
Page 1
Reviewing the Potential of Psychedelics for the Treatment of PTSD.
Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. Krediet E, et al. Int J Neuropsychopharmacol. 2020 Jun 24;23(6):385-400. doi: 10.1093/ijnp/pyaa018. Int J Neuropsychopharmacol. 2020. PMID: 32170326 Free PMC article. Review.
Default Mode Network Modulation by Psychedelics: A Systematic Review.
Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J. Gattuso JJ, et al. Int J Neuropsychopharmacol. 2023 Mar 22;26(3):155-188. doi: 10.1093/ijnp/pyac074. Int J Neuropsychopharmacol. 2023. PMID: 36272145 Free PMC article.
Circuit Mechanisms of Reward, Anhedonia, and Depression.
Höflich A, Michenthaler P, Kasper S, Lanzenberger R. Höflich A, et al. Int J Neuropsychopharmacol. 2019 Feb 1;22(2):105-118. doi: 10.1093/ijnp/pyy081. Int J Neuropsychopharmacol. 2019. PMID: 30239748 Free PMC article. Review.
Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders.
Fregni F, El-Hagrassy MM, Pacheco-Barrios K, Carvalho S, Leite J, Simis M, Brunelin J, Nakamura-Palacios EM, Marangolo P, Venkatasubramanian G, San-Juan D, Caumo W, Bikson M, Brunoni AR; Neuromodulation Center Working Group. Fregni F, et al. Int J Neuropsychopharmacol. 2021 Apr 21;24(4):256-313. doi: 10.1093/ijnp/pyaa051. Int J Neuropsychopharmacol. 2021. PMID: 32710772 Free PMC article.
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Gómez-Revuelta M, Pelayo-Terán JM, Juncal-Ruiz M, Vázquez-Bourgon J, Suárez-Pinilla P, Romero-Jiménez R, Setién Suero E, Ayesa-Arriola R, Crespo-Facorro B. Gómez-Revuelta M, et al. Int J Neuropsychopharmacol. 2020 Apr 23;23(4):217-229. doi: 10.1093/ijnp/pyaa004. Int J Neuropsychopharmacol. 2020. PMID: 31974576 Free PMC article. Clinical Trial.
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).
Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Ionescu DF, et al. Int J Neuropsychopharmacol. 2021 Jan 20;24(1):22-31. doi: 10.1093/ijnp/pyaa068. Int J Neuropsychopharmacol. 2021. PMID: 32861217 Free PMC article. Clinical Trial.
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
Ekstrand J, Fattah C, Persson M, Cheng T, Nordanskog P, Åkeson J, Tingström A, Lindström MB, Nordenskjöld A, Movahed Rad P. Ekstrand J, et al. Int J Neuropsychopharmacol. 2022 May 27;25(5):339-349. doi: 10.1093/ijnp/pyab088. Int J Neuropsychopharmacol. 2022. PMID: 35020871 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.
Najarian D, Sanga P, Wang S, Lim P, Singh A, Robertson MJ, Cohen K, Schotte A, Milz R, Venkatasubramanian R, T'Jollyn H, Walling DP, Galderisi S, Gopal S. Najarian D, et al. Int J Neuropsychopharmacol. 2022 Mar 17;25(3):238-251. doi: 10.1093/ijnp/pyab071. Int J Neuropsychopharmacol. 2022. PMID: 34791283 Free PMC article. Clinical Trial.
2,609 results